Search / Trial NCT06228027

External Validation os the ACME Scoring System

Launched by HOSPITAL DEL MAR · Jan 18, 2024

Trial Information

Current as of December 22, 2024

Not yet recruiting

Keywords

Acute Cholecystitis Cholecystectomy Tokyo Guidelines Postoperative Complications Mortality High Risk Patient

ClinConnect Summary

This is a prospective multicenter observational study of 10.000 adults with ACC during 2 consecutive years (2025/2026), including baseline demographic characteristics, comorbidity severity defined as Charlson Comorbidity Index (CCI), ASA Score, Tokyo Guidelines severity classification and the new ACME Scoring system. The primary outcome is to study the prediction of mortality of ACME score. Secondary outcomes include complications following Clavien-Dindo's classification, C-statistic, and ROC Curves.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Acute Calculous Cholecystitis
  • Exclusion Criteria:
  • Acute Cholangitis
  • Chronic Cholecystitis
  • Neoplasia
  • Acute Pancreatitis
  • Pregnant

Trial Officials

Ana María González Castillo, PhD

Principal Investigator

Hospital del Mar

About Hospital Del Mar

Hospital del Mar is a leading healthcare institution located in Barcelona, Spain, renowned for its commitment to medical excellence and patient care. As a prominent clinical trial sponsor, Hospital del Mar actively engages in innovative research aimed at advancing medical knowledge and improving therapeutic outcomes across various specialties. The hospital boasts a multidisciplinary team of experienced researchers and healthcare professionals dedicated to conducting rigorous clinical trials in accordance with the highest ethical and regulatory standards. Through collaboration with academic institutions and industry partners, Hospital del Mar strives to translate research findings into tangible benefits for patients, enhancing the quality of care within the community and beyond.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0